Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
5.05
+0.13 (2.64%)
At close: Apr 10, 2026, 4:00 PM EDT
5.10
+0.05 (0.99%)
After-hours: Apr 10, 2026, 7:35 PM EDT
Q32 Bio Revenue
In the year 2025, Q32 Bio had annual revenue of $53.74M. Q32 Bio had revenue of $53.74M in the quarter ending December 31, 2025.
Revenue (ttm)
$53.74M
Revenue Growth
n/a
P/S Ratio
1.37
Revenue / Employee
$2,239,042
Employees
24
Market Cap
73.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.74M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | -6.65M | -9.86M | - |
| Dec 31, 2022 | 3.21M | -30.76M | -90.56% |
| Dec 31, 2021 | 33.97M | 31.27M | 1,157.25% |
| Dec 31, 2020 | 2.70M | 1.04M | 62.18% |
| Dec 31, 2019 | 1.67M | -3.66M | -68.70% |
| Dec 31, 2018 | 5.32M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gossamer Bio | 48.47M |
| Pelthos Therapeutics | 16.80M |
| Alterity Therapeutics | 4.43M |
| NeurAxis | 3.57M |
| Rani Therapeutics Holdings | 1.63M |
| iBio, Inc. | 300.00K |
| aTyr Pharma | 190.00K |
QTTB News
- 3 days ago - Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 4 weeks ago - Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 7 weeks ago - Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference - PRNewsWire
- 7 weeks ago - Q32 Bio Announces $10.5 Million Registered Direct Offering - PRNewsWire
- 4 months ago - Dow Dips 200 Points; Q32 Bio Shares Jump - Benzinga
- 4 months ago - Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - Benzinga
- 4 months ago - Q32 Bio Sells Complement Inhibitor ADX-097 - PRNewsWire
- 5 months ago - Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire